Retail won't get a look in, ~85% of us are already sitting on the $1.25 oppies.
And on that point, if there is a raise, I think it would be remiss for T to participate in any capacity, given the amount of 'in the money' options he's currently sitting on.
Who knows, they might license a new molecule or geographic region to bolster reserves and expand programs. Hell, they might not even need the extra cash if they never get it to the clinic, right
And no, I'm not grooming you.
RAC Price at posting:
$1.47 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)